Massachusetts Institute of Technology MIT

Warning LetterOpen

United StatesIssued Jun 21, 2024Center for Biologics Evaluation and Research (CBER)

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations0

Issue DateJun 21, 2024

Product TypeBiologics

StatusOpen

Letter Details

Firm: Massachusetts Institute of Technology MIT
Location: United States
FEI Number: N/A
Country: United States
Issue Date: June 21, 2024
Issuing Office: Center for Biologics Evaluation and Research (CBER)
Product Type: Biologics
Status: Open

Summary

Based on limited metadata, the FDA issued a Warning Letter to Massachusetts Institute of Technology on June 21, 2024, regarding biologics products or manufacturing practices. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning falls under FDA biologics regulation, though the specific issuing office is not identified in the metadata provided. Further review of the complete Warning Letter would be necessary to identify the specific compliance issues cited.

Massachusetts Institute of Technology MIT FDA Warning Letter, June 21, 2024